GR3034862T3 - Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones. - Google Patents

Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones.

Info

Publication number
GR3034862T3
GR3034862T3 GR20000402552T GR20000402552T GR3034862T3 GR 3034862 T3 GR3034862 T3 GR 3034862T3 GR 20000402552 T GR20000402552 T GR 20000402552T GR 20000402552 T GR20000402552 T GR 20000402552T GR 3034862 T3 GR3034862 T3 GR 3034862T3
Authority
GR
Greece
Prior art keywords
gallium
pharmaceutical compositions
pyrones
hydroxy
certain
Prior art date
Application number
GR20000402552T
Other languages
English (en)
Inventor
Lawrence Richard Bernstein
Original Assignee
Lawrence Richard Bernstein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lawrence Richard Bernstein filed Critical Lawrence Richard Bernstein
Publication of GR3034862T3 publication Critical patent/GR3034862T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR20000402552T 1991-11-12 2000-11-15 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones. GR3034862T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1991/008239 WO1993009776A1 (en) 1991-11-12 1991-11-12 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
CA002122908A CA2122908C (en) 1991-11-12 1991-11-12 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones

Publications (1)

Publication Number Publication Date
GR3034862T3 true GR3034862T3 (en) 2001-02-28

Family

ID=25677246

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000402552T GR3034862T3 (en) 1991-11-12 2000-11-15 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones.

Country Status (10)

Country Link
EP (1) EP0612246B1 (el)
JP (1) JP3348849B2 (el)
KR (1) KR100217001B1 (el)
AT (1) ATE195868T1 (el)
CA (1) CA2122908C (el)
DE (1) DE69132392T2 (el)
DK (1) DK0612246T3 (el)
ES (1) ES2151486T3 (el)
GR (1) GR3034862T3 (el)
WO (1) WO1993009776A1 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747482A (en) * 1996-07-30 1998-05-05 Bernstein; Lawrence R. Methods and compositions to inhibit keratinocyte proliferation
JP2003510362A (ja) * 1999-10-04 2003-03-18 ローレンス・アール・バーンスタイン 細胞内原核生物、ｄｎａウイルス及びレトロウイルスによる感染を治療するための、３−ヒドロキシ−４−ピロンのガリウム錯体
DE10113185A1 (de) * 2001-03-19 2002-10-24 Faustus Forschungs Cie Zusammensetzung, enthaltend einen Gallium(III)-Komplex und einen therapeutisch wirksamen Platin-Komplex
MXPA06006801A (es) * 2003-12-17 2007-01-26 Titan Pharmaceuticals Inc Uso de galio para tratar artritis inflamatoria.
CN102665421A (zh) * 2009-03-30 2012-09-12 尼基制药公司 治疗骨质疏松的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB9006522D0 (en) * 1990-03-23 1990-05-23 Hider Robert C Metal complexes
WO1991017751A1 (en) * 1990-05-24 1991-11-28 Fujisawa, Inc. Orally administrable gallium compositions and methods of treatment therewith

Also Published As

Publication number Publication date
WO1993009776A1 (en) 1993-05-27
JP3348849B2 (ja) 2002-11-20
DE69132392D1 (de) 2000-10-05
CA2122908C (en) 2004-08-17
ES2151486T3 (es) 2001-01-01
JPH07504153A (ja) 1995-05-11
EP0612246A1 (en) 1994-08-31
EP0612246A4 (en) 1995-04-19
KR100217001B1 (ko) 1999-09-01
DK0612246T3 (da) 2000-12-27
DE69132392T2 (de) 2001-06-07
ATE195868T1 (de) 2000-09-15
EP0612246B1 (en) 2000-08-30
CA2122908A1 (en) 1993-05-27

Similar Documents

Publication Publication Date Title
BG104727A (en) Pharmaceutical composition of topiramate
KR940703676A (ko) 알렌드로네이트를 사용한 치근막 질환의 치료방법(Treatment of periodontal disease with alendronate)
TW200744673A (en) Improved ibandronate formulations
BR122012014331B8 (pt) formulações farmacêuticas
NL990012I1 (nl) Geneesmiddelen die salmeterol en fluticason bevatten.
BG101118A (en) Therapeutical compounds
MX16658A (es) Procedimiento para la preparacion de derivados delacido difosfonico producto obtenido y composicion farmaceutica para el tratamiento de desordenes en el metabolismo del calcio que lo incluye.
BR0011867A (pt) Preparação farmacêutica de levodopa/carbidopa/entacapona
TR200101633T2 (tr) Farmasötik bileşim
ES2153906T3 (es) Uso de incienso para el tratamiento de la enfermedad de alzheimer.
DE69919533D1 (de) Proteinhaltige arzneimittel
KR970009582B1 (en) Method for the treatment of oste oporosis and related disorders
BR9915729A (pt) Amidas Èmega de n-arilsulfonil-aminoácido
GR3034862T3 (en) Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones.
FR2500303B1 (el)
IS1801B (is) Pýridýlbisfosfónöt til notkunar sem efni til lækninga
ES2042831T3 (es) Procedimiento de preparacion de una composicion farmaceutica para el tratamiento de la osteoporosis.
GB8921516D0 (en) Medicaments
BR9917605A (pt) Composição substituta de plasma
JPS554397A (en) Novel n11benzoylln22phenyll1*33diaminopropane 22ol*its manufacture and medicine containing it for therapy of acute and chronic gastritis
DE69318418D1 (de) Pharmazeutische zusammensetzungen, die 5-ht 1-rezeptoragonisten und absorptionsverstärker enthalten
IT1244714B (it) Uso della benzidamina per il trattamento della placca dentaria

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees